Aquestive Therapeutics, Inc. IPO Research Information

Aquestive Therapeutics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Aquestive Therapeutics, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Aquestive Therapeutics, Inc.	AQST - NASDAQ	$14.00-$16.00	$15.00	$15.05	4.5 million	7/25/2018
Underwriter(s): BMO, RBC
Co-Manager(s): JMP Securities, Wedbush
Industry: Health Care
Filing(s): Filed 2018-06-27 Terms Added 2018-07-16

Aquestive Therapeutics, Inc. Quote & Chart - Click for current quote - AQST

About Aquestive Therapeutics, Inc. (adapted from Aquestive Therapeutics, Inc. prospectus):
They are a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to address unmet medical needs.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "AQST" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.